Research collaboration

Cambridge joins consortium to launch £40M Apollo Therapeutics Fund

Three global pharmaceutical companies and the technology transfer offices of three world-leading universities – Imperial College London, University College London and the University of Cambridge – have joined forces with a combined £40M to create the Apollo Therapeutics Fund
27 Jan 2016